Bollard Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $333K | Buy |
4,253
+34
| +0.8% | +$2.74K | 0.01% | 147 |
|
|
2026
Q1 | $366K | Buy |
4,219
+30
| +0.7% | +$2.87K | 0.01% | 149 |
|
|
2025
Q4 | $402K | Buy |
4,189
+30
| +0.7% | +$2.91K | 0.01% | 143 |
|
|
2025
Q3 | $396K | Buy |
4,159
+32
| +0.8% | +$2.94K | 0.01% | 142 |
|
|
2025
Q2 | $360K | Buy |
4,127
+33
| +0.8% | +$2.8K | 0.01% | 164 |
|
|
2025
Q1 | $368K | Buy |
4,094
+34
| +0.8% | +$3.04K | 0.01% | 147 |
|
|
2024
Q4 | $324K | Sell |
4,060
-2,969
| -42% | -$257K | 0.01% | 146 |
|
|
2024
Q3 | $633K | Buy |
7,029
+35
| +0.5% | +$2.94K | 0.02% | 135 |
|
|
2024
Q2 | $551K | Buy |
6,994
+33
| +0.5% | +$2.71K | 0.02% | 133 |
|
|
2024
Q1 | $607K | Buy |
6,961
+30
| +0.4% | +$2.56K | 0.02% | 129 |
|
|
2023
Q4 | $571K | Sell |
6,931
-54
| -0.8% | -$4.12K | 0.02% | 124 |
|
|
2023
Q3 | $547K | Buy |
6,985
+30
| +0.4% | +$2.51K | 0.02% | 120 |
|
|
2023
Q2 | $613K | Buy |
6,955
+121
| +2% | +$10.4K | 0.02% | 127 |
|
|
2023
Q1 | $551K | Buy |
6,834
+3,032
| +80% | +$247K | 0.02% | 126 |
|
|
2022
Q4 | $296K | Buy |
3,802
+30
| +0.8% | +$2.43K | 0.01% | 145 |
|
|
2022
Q3 | $305K | Buy |
3,772
+27
| +0.7% | +$2.43K | 0.01% | 146 |
|
|
2022
Q2 | $336K | Sell |
3,745
-5,442
| -59% | -$551K | 0.01% | 150 |
|
|
2022
Q1 | $1.02M | Buy |
9,187
+53
| +0.6% | +$5.6K | 0.03% | 136 |
|
|
2021
Q4 | $945K | Buy |
9,134
+46
| +0.5% | +$5.33K | 0.03% | 142 |
|
|
2021
Q3 | $1.14M | Buy |
9,088
+44
| +0.5% | +$5.7K | 0.04% | 128 |
|
|
2021
Q2 | $1.12M | Buy |
9,044
+42
| +0.5% | +$5.27K | 0.04% | 122 |
|
|
2021
Q1 | $1.06M | Buy |
9,002
+10
| +0.1% | +$1.17K | 0.04% | 121 |
|
|
2020
Q4 | $1.05M | Sell |
8,992
-179
| -2% | -$19.7K | 0.04% | 117 |
|
|
2020
Q3 | $953K | Buy |
9,171
+12
| +0.1% | +$1.21K | 0.03% | 121 |
|
|
2020
Q2 | $840K | Buy |
9,159
+5,364
| +141% | +$514K | 0.03% | 118 |
|
|
2020
Q1 | $342K | Buy |
3,795
+10
| +0.3% | +$1.06K | 0.02% | 130 |
|
|
2019
Q4 | $429K | Buy |
3,785
+11
| +0.3% | +$1.21K | 0.01% | 137 |
|
|
2019
Q3 | $410K | Buy |
3,774
+12
| +0.3% | +$1.25K | 0.01% | 138 |
|
|
2019
Q2 | $366K | Buy |
3,762
+12
| +0.3% | +$1.1K | 0.01% | 155 |
|
|
2019
Q1 | $342K | Buy |
3,750
+13
| +0.3% | +$1.16K | 0.01% | 155 |
|
|
2018
Q4 | $340K | Buy |
3,737
+11
| +0.3% | +$1.03K | 0.02% | 153 |
|
|
2018
Q3 | $366K | Buy |
3,726
+15
| +0.4% | +$1.39K | 0.01% | 152 |
|
|
2018
Q2 | $318K | Buy |
3,711
+16
| +0.4% | +$1.34K | 0.01% | 156 |
|
|
2018
Q1 | $296K | Buy |
3,695
+14
| +0.4% | +$1.16K | 0.01% | 159 |
|
|
2017
Q4 | $297K | Buy |
3,681
+15
| +0.4% | +$1.2K | 0.01% | 154 |
|
|
2017
Q3 | $285K | Buy |
3,666
+15
| +0.4% | +$1.25K | 0.02% | 164 |
|
|
2017
Q2 | $324K | Buy |
3,651
+14
| +0.4% | +$1.18K | 0.02% | 163 |
|
|
2017
Q1 | $293K | Buy |
3,637
+14
| +0.4% | +$1.09K | 0.02% | 166 |
|
|
2016
Q4 | $258K | Buy |
3,623
+1,800
| +99% | +$141K | 0.02% | 173 |
|
|
2016
Q3 | $158K | Buy |
1,823
+275
| +18% | +$24K | 0.01% | 186 |
|
|
2016
Q2 | $134K | Buy |
1,548
+2
| +0.1% | +$162 | 0.01% | 191 |
|
|
2016
Q1 | $116K | Buy |
1,546
+3
| +0.2% | +$226 | 0.01% | 194 |
|
|
2015
Q4 | $119K | Buy |
1,543
+3
| +0.2% | +$226 | 0.01% | 196 |
|
|
2015
Q3 | $103K | Buy |
1,540
+2
| +0.1% | +$147 | 0.01% | 214 |
|
|
2015
Q2 | $114K | Buy |
1,538
+2
| +0.1% | +$153 | 0.01% | 209 |
|
|
2015
Q1 | $120K | Buy |
1,536
+6
| +0.4% | +$455 | 0.01% | 205 |
|
|
2014
Q4 | $110K | Buy |
1,530
+8
| +0.5% | +$556 | 0.01% | 199 |
|
|
2014
Q3 | $94K | Buy |
1,522
+4
| +0.3% | +$254 | 0.01% | 217 |
|
|
2014
Q2 | $97K | Buy |
1,518
+5
| +0.3% | +$304 | 0.01% | 213 |
|
|
2014
Q1 | $93K | Buy |
1,513
+5
| +0.3% | +$291 | 0.01% | 213 |
|
|
2013
Q4 | $87K | Buy |
1,508
+602
| +66% | +$34.1K | 0.01% | 209 |
|
|
2013
Q3 | $48K | Buy |
+906
| New | +$48.8K | 0.01% | 229 |
|
Other funds holding MDT
Bollard Group's MDT Position: Q2 2026 in Review
Bollard Group increased its Medtronic (MDT) stake by 0.81% in Q2 2026, buying an estimated $2.74K and bringing the position to 4,253 shares worth $333K. The position accounts for 0.01% of the portfolio, ranked #147.
Bollard Group first reported a position in MDT in Q3 2013 and has held it in 52 quarters since. The position peaked at $1.14M in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Bollard Group held 4,253 shares of Medtronic worth $333K as of Q2 2026.
- Bollard Group bought 34 Medtronic shares in Q2 2026, an estimated $2.74K.
- Medtronic made up 0.01% of Bollard Group's portfolio in Q2 2026, its #147 holding.
- Bollard Group first reported a position in Medtronic in Q3 2013 and has held it in 52 quarters since.
- Bollard Group's Medtronic position peaked at $1.14M in Q3 2021.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Bollard Group's 13F filing for Q2 2026, filed 12 Aug 2026.